PubRank

J H Finke

Author PubWeight™ 36.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J Immunol 1998 1.72
2 Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology 1984 1.49
3 Splenic T-killer cells can be generated by allogeneic thymic cells in conjunction with assisting factor. Nature 1977 1.32
4 Interleukin 2 deficiency in murine Leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin. J Immunol 1983 1.25
5 Adult murine lymph node cells respond blastogenically to a new differentiation antigen on isologous and autologous B lymphocytes. J Immunol 1975 1.22
6 Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2. J Immunol 1983 1.12
7 Interferon gamma and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages. J Biol Chem 1990 1.09
8 Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Clin Cancer Res 1999 1.09
9 Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells. J Clin Invest 1999 1.02
10 Placental mononuclear phagocytes as a source of interleukin-1. Science 1982 0.97
11 Alterations in NFkappaB activation in T lymphocytes of patients with renal cell carcinoma. J Natl Cancer Inst 1999 0.94
12 Dead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma. Cancer Res 1999 0.93
13 Caspase-dependent and -independent death pathways in cancer therapy. Apoptosis 2000 0.92
14 Mechanism of apoptosis induced by zinc deficiency in peripheral blood T lymphocytes. Apoptosis 2001 0.90
15 Defective granzyme B gene expression and lytic response in T lymphocytes infiltrating human renal cell carcinoma. J Immunother 1997 0.88
16 Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy. Clin Cancer Res 1998 0.88
17 Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis. Oncogene 2012 0.86
18 Generation of alloreactive cytotoxic T lymphocytes: production of T cell and macrophage helper factors in addition to IL 1 and IL 2 by peritoneal cells from mice immunized to Listeria monocytogenes. J Immunol 1981 0.86
19 IFN-gamma and IL-2 cooperatively activate NF kappa B in murine peritoneal macrophages. J Immunol 1992 0.86
20 Reversal of phorbol ester-mediated reduction of cloned T lymphocyte cytolysis by interleukin 2. J Immunol 1985 0.85
21 Soluble helper factor(s) participates in the generation of cell mediated cytotoxicity directed against syngeneic tumor cells. J Immunol 1979 0.85
22 In vitro and ex vivo toxicological testing of sildenafil-loaded solid lipid nanoparticles. Inhal Toxicol 2013 0.84
23 Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape. Cancer J Sci Am 2000 0.84
24 T-cell adoptive therapy of tumors: mechanisms of improved therapeutic performance. Crit Rev Immunol 2001 0.84
25 Interleukin 7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma. Int J Cancer 1993 0.82
26 Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2. Am J Pathol 1994 0.82
27 Responses to T cell receptor/CD3 and interleukin-2 receptor stimulation are altered in T cells from B cell non-Hodgkin's lymphomas. Cancer Immunol Immunother 1995 0.81
28 Interactive effects of alpha-interferon A/D and interleukin 2 on murine lymphokine-activated killer activity: analysis at the effector and precursor level. Cancer Res 1990 0.80
29 Induction by interleukin-2 of oligoclonal expansion of cultured tumor-infiltrating lymphocytes. J Natl Cancer Inst 1990 0.79
30 H-2K/H-2D and Mls and I region-associated antigens stimulate helper factor(s) involved in the generation of cytotoxic T lymphocytes. J Immunol 1980 0.78
31 Comparison of interleukin 1 production by adherent cells and tissue pieces from human placenta. Immunopharmacology 1985 0.78
32 Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12. J Immunother 1999 0.78
33 Tumor-infiltrating lymphocytes: new therapy, new hopes. Gastroenterology 1990 0.77
34 T lymphocytes infiltrating renal cell carcinoma have a reduced expression of transferrin receptor. Int J Cancer 1994 0.77
35 Influence of killer assisting factor (KAF) on generation of cytotoxic T cells. Cell Immunol 1978 0.77
36 Cellular uptake of coumarin-6 under microfluidic conditions into HCE-T cells from nanoscale formulations. Mol Pharm 2014 0.76
37 Inactivation of complement by Loxosceles reclusa spider venom. Am J Trop Med Hyg 1979 0.76
38 Inhibition of NFkappaB induces caspase-independent cell death in human T lymphocytes. Biochem Biophys Res Commun 2001 0.76
39 Pleiotropic effects of cytokines: clinical and preclinical studies. Stem Cells 1994 0.76
40 Resident research award: tumor necrosis factor alpha selectively enhances growth and cytotoxic activity of tumor infiltrating lymphocytes from human colorectal cancer. J Surg Res 1992 0.76
41 Capacity to interact with T-cell replacing factor correlates with acquisition by B cells of murine differentiation antigen-1. Immunology 1979 0.75
42 A murine leukemia virus yield-reduction semi-microassay for interferon. J Virol Methods 1980 0.75
43 Correlation of B cell acquisition of differentiation antigens with capacity to interact with allogeneic effect factor (AEF). Adv Exp Med Biol 1979 0.75
44 Genetic restriction of interferon production in immune response to Listeria monocytogenes. J Interferon Res 1982 0.75
45 CTL helper factor(s) produced by peritoneal cells of mice immunized to Listeria monocytogenes: relationship to interferon. J Interferon Res 1981 0.75
46 Phorbol ester-inactivation of cloned cytotoxic T lymphocytes: restoration of lytic activity by interleukin 2 and induction of interferon production are separable events. Lymphokine Res 1985 0.75
47 The immunogenic and tumorigenic properties of a murine lymphoma that expresses foreign alloantigens: role of helper factor(s) in generating a cytotoxic response in vitro. Transplant Proc 1981 0.75
48 Isogeneic and allogeneic lymphocyte interactions may be controlled by cell surface immunoglobulin tropism. Cell Immunol 1976 0.75
49 23 assessment of T-cell immune dysfunction in patients with renal cell carcinoma. Methods Mol Med 2001 0.75
50 Immunoregulatory aspects of in vivo syngeneic mixed lymphocyte reactions. Behring Inst Mitt 1983 0.75
51 The T cell death knell: immune-mediated tumor death in renal cell carcinoma. Clin Cancer Res 2001 0.75
52 Characterization of "foreign" alloantigen-like specificities on a murine lymphoma cell line. Transplant Proc 1980 0.75
53 Case report. Aplastic anemia. Effect of antithymocyte globulin on erythroid colony formation. Cleve Clin Q 1978 0.75
54 Therapeutic efficacy of interleukin-2 activated killer cells against adriamycin resistant mouse B16-BL6 melanoma. Anticancer Res 1992 0.75
55 Serodiagnostic test for Loxosceles reclusa bites. Clin Toxicol 1974 0.75
56 In vitro activation of lymphocytes by interleukin 2 in patients with renal cell carcinoma. Urology 1989 0.75